ImClone Closing Branchburg, New Jersey Manufacturing Facility
08/17/2010
"This decision was made after careful consideration of a number of internal and external factors related to Erbitux [a cancer drug]," said Janice Chavers, an Eli Lilly spokesperson. "The decision was not driven by Lilly's larger restructuring effort."
ImClone currently has 90 open positions for which employees affected by the layoffs will have priority. The closure plans are effective immediately.
Project Announcements
Swiss-Based GF Casting Solutions AG Plans Augusta, Georgia, Operations
05/07/2024
3M Expands Valley, Nebraska, Production Operations
05/07/2024
Advanced Call Center Technologies Expands Norman, Oklahoma, Operations
05/07/2024
Rivian Automotive Expands Normal, Illinois, Operations
05/06/2024
Meta Platforms Plans Montgomery, Alabama, Data Center Operations
05/06/2024
Crystal Window & Door Systems Plans Selma, North Carolina, Production Operations
05/06/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
Last Word: Striking a Balance - Prioritizing Electric Infrastructure While Preparing for the Next Wave of Industrial Expansion
Q1 2024